Dual inhibition of JAK3 and PD-L1 boosts immune response in triple negative breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Huali,Xiang

第一单位： Physical Examination Department, Jiangxi Maternal and Child Health Hospital.

作者： Huali,Xiang ^[1] ; Binfeng,Tu ^[2] ; Xin,Feng ^[3] ; Linjing,Chen ^[4] ; Yajuan,Huang ^[5]

作者单位： Physical Examination Department, Jiangxi Maternal and Child Health Hospital. ^[1] Neurosurgery Department, Jiangxi Cancer Hospital. ^[2] Hospital Health Education Department. ^[3] Ultrasound Department. ^[4] Galactophore Department, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China. ^[5]

DOI 10.1097/CAD.0000000000001685

PMID 39774369

发布时间 2025-01-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Anti-cancer drugs

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dual inhibition of JAK3 and PD-L1 boosts immune response in triple negative breast cancer.

Anti-cancer drugs

相似文献

Anti-cancer drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dual inhibition of JAK3 and PD-L1 boosts immune response in triple negative breast cancer.

Anti-cancer drugs

相似文献

Anti-cancer drugs

相关期刊

检索历史清除